Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Tipo de estudo
Intervalo de ano de publicação
1.
Eur J Paediatr Dent ; 24(4): 334-336, 2023 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-38015115

RESUMO

BACKGROUND: Mandibulofacial dysostosis Guion-Almeida Type (MFDGA; OMIM#610536) is a rare autosomal dominant genetic disorder caused by heterozygous pathogenic variants in the EFTUD2 gene. Mandibulofacial dysostoses are characterised by the core triad malar hypoplasia, maxillary hypoplasia and dysplastic ears, all derived by the impaired development of the first and second branchial arches. Differential diagnosis is often challenging. The early genetic diagnosis is extremely useful, not only for the correct management of cranial malformations, but also for the early diagnosis and treatment of the comorbidities associated to the disease, which greatly benefit from early treatment.


Assuntos
Região Branquial , Disostose Mandibulofacial , Humanos , Disostose Mandibulofacial/genética , Diagnóstico Diferencial , Zigoma , Fatores de Alongamento de Peptídeos , Ribonucleoproteína Nuclear Pequena U5
2.
Eur J Clin Pharmacol ; 76(5): 731-732, 2020 May.
Artigo em Inglês | MEDLINE | ID: mdl-31938857

RESUMO

Adverse drug reactions occur at a high rate in hospitalized children, frequently due to antiepileptic drug administration. Phenytoin is a commonly used drug, and its metabolism is mediated by a specific cytochrome-P450 isoform, CYP2C9, which is encoded by a polymorphic gene. It is worth noting that very frequently administered drugs, such as proton pump inhibitors, compete with phenytoin for CYP2C19-mediated metabolism. Here we describe a case of phenytoin intoxication in a child with defective CYP2C9, after omeprazole administration.


Assuntos
Citocromo P-450 CYP2C9/metabolismo , Omeprazol/administração & dosagem , Fenitoína/efeitos adversos , Pré-Escolar , Citocromo P-450 CYP2C19/metabolismo , Citocromo P-450 CYP2C9/genética , Interações Medicamentosas , Genótipo , Humanos , Fenitoína/sangue , Polimorfismo Genético
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA